Cost-effectiveness analysis for priority setting in health: Penny-wise but pound-foolish

International Journal of Technology Assessment in Health Care

Volumn 21, Issue 4, 2005, Pages 532-534

  Baltussen, Rob ^a   Brouwer, Werner ^a   Niessen, Louis ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Cost effectiveness; Economic evaluation; Methodology; Priority setting

Indexed keywords

ECONOMIC EVALUATION; METHODOLOGY; POLICY-MAKERS; PRIORITY SETTING;

BIOTECHNOLOGY; COST EFFECTIVENESS; EVALUATION; PUBLIC POLICY;

HEALTH CARE;

COST EFFECTIVENESS ANALYSIS; DEVELOPING COUNTRY; ECONOMIC EVALUATION; HEALTH CARE COST; HEALTH CARE MANAGEMENT; HEALTH CARE POLICY; HEALTH ECONOMICS; MEDICAL RESEARCH; METHODOLOGY; REVIEW;

BIOMEDICAL TECHNOLOGY; COST-BENEFIT ANALYSIS; DEVELOPED COUNTRIES; DEVELOPING COUNTRIES; HEALTH POLICY; HEALTH PRIORITIES;

EID: 27844540391     PISSN: 02664623     EISSN: 14716348     Source Type: Journal    
DOI: 10.1017/S0266462305050750     Document Type: Review

References (21)

1. Bobadilla JL, Cowley P, Musgrove P, Saxenian H. Design, content and financing of an essential national package of health services. Bull World Health Organ. 1994;72:653-662.
2. Bryant J, Cave C, Mihaylova B, et al. Clinical effectiveness and cost-effectiveness of growth hormone in children: A systematic review and economic evaluation. Health Technol Assess. 2002;6:1-168.
3. Churchill RHV, Corney R, Knapp M, et al. A systematic review of controlled trials of the effectiveness and cost-effectiveness of brief psychological treatments for depression. Health Technol Assess. 2001;5:1-173.
4. Eichler HG, Kong SX, Gerth WC, Mavros P, Jonsson B. Use of cost-effectiveness analysis in health-care resource allocation decision-making: How are cost-effectiveness thresholds expected to emerge? Value Health. 2004;7:518-528.
5. EuroScan. The European Information Network on New and Changing Health Technologies. Available at: http://www.publichealth.bham.ac.uk/euroscan/members/ current.htm. Accessed May 15, 2005.
6. Gafni A, Birch S. NICE methodological guidelines and decision making in the National Health Service in England and Wales. Pharmacoeconomics. 2003;21:149-157.
7. Holloway RG, Benesch CG, Rahilly CR, Courtright CE. A systematic review of cost-effectiveness research of stroke evaluation and treatment. Stroke. 1999;30:1340-1349.
8. Jamison DT, Mosley WH, Measham AR, Bobadilla JL. Disease control priorities in developing countries. New York: Oxford University Press; 1993.
9. Klonoff DC, Schwartz DM. An economic analysis of interventions for diabetes. Diabetes Care 2000;23:390-404.
10. Murray CJ, Evans DB, Acharya A, BaltussenRM. Development of WHO guidelines on generalized cost-effectiveness analysis. Health Econ. 2000;9:235-251.
11. Norderhaug I, Dahl O, Hoisaeter PA, et al. Brachytherapy for prostate cancer: A systematic review of clinical and cost effectiveness. Eur Urol. 2003;44:40-46.
12. Oregon, HSC. Oregon Medicaid priority setting project. Eugene: Oregon State Government; 1991.
13. Pignone M, Saha S, Hoerger T, Mandelblatt J. Cost-effectiveness analyses of colorectal cancer screening: A systematic review for the U.S. Preventive Services Task Force. Ann Intern Med. 2002;137:96-104.
14. Robinson R. Limits to rationality: Economics, economists and priority setting. Health Policy. 1999;49:13-26.
15. Rutten FE, Brouwer WB. Meer zorg bij beperkt budget; een pleidooi voor een betere inzet van het doelmatigheidscriterium (in Dutch). Ned Tijdsch v Geneesk. 2002;146:2254-2258.
16. Stinnett AA, Paltiel AD. Mathematical programming for the efficient allocation of health care resources. J Health Econ. 1996;15:641-653.
17. Tan Torres T, Baltussen R, Adam T. et al. WHO guide to cost-effectiveness analysis. Geneva: World Health Organization; 2003.
18. Tella MN, Feinglass J, Chang RW. Cost-effectiveness, cost-utility, and cost-benefit studies in rheumatology: A review of the literature, 2001-2002. Curr Opin Rheumatol. 2003;15:127-131.
19. Tenbesnel T. Interpreting public input into priority-setting: The role of mediating institutions. Health Policy. 2002;62:173-194.
20. Tengs TO, Adams ME, Pliskin JS, et al. Five-hundred life-saving interventions and their cost-effectiveness. Risk Anal. 1995;15:369-390.
21. Weinstein MC, Stason WB. Foundations of cost-effectiveness analysis for health and medical practices. N Engl J Med. 1977;296:716-721.